Pharmaceutical composition
Abstract
Phenylalinine derivatives having the general formula: and their non-toxic salts, have been found to promote the absorption of medicinal substances such as insulin. In the above formula, R' is a hydrogen atom, a fluorine atom, a nitro group, a hydroxyl group or a hydroxyl group protected by an esterifying group, X is -CO- or -SO2-, -Y- is a straight bond, a lower alkylene group, a substituted or unsubstituted vinylene group, or a group having the form- fula -CH2-O- or -0-CH2-, and R2 is a substituted or unsubstituted phenyl or naphthyl group; or the group R2-Y-CO- is an N-benzyloxy-carbonylphenylalanyl group, an N-benzyloxycarbonyl-4-flurophenylalanyl group or an N-(m-methoxycinnamoyl)phenylalanyl group.

Term
Term ended
Projected expiry passed 22 April 2003, 23.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
1 sheet
Sheet 1
Every citation, both ways
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| GB2095994A | Cites | United Kingdom | Y | Search report |
13 members in 6 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 7330682 | Japan | A | |
| 7330682 | Japan | – | |
| 6599983 | Japan | A | |
| 6599983 | Japan | – | |
| 6599983 | – | – | – |
| 7330682 | – | – | – |
| JP19820073306 | – | – | – |
| JP19830065999 | – | – | – |
Members13
| Document | Office | Kind | |
|---|---|---|---|
| DK192583D0 | Denmark | D0 | |
| DK192583A | Denmark | A | |
| JPS58189121A | Japan | A | |
| EP0093551A2 | European Patent Office (EPO) | A2 | |
| JPS59190926A | Japan | A | |
| EP0093551A3This record | European Patent Office (EPO) | A3 | |
| US4650785A | United States of America | A | |
| US4670584A | United States of America | A | |
| CA1250090A | Canada | A | |
| EP0093551B1 | European Patent Office (EPO) | B1 | |
| DE3382112D1 | Germany | D1 | |
| JPH0518813B2 | Japan | B2 | |
| DK170855B1 | Denmark | B1 |
21 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Notification of lapseLapsedST | ST | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Fr: translation filedET | ET | EP | |
| Corresponds to:REF | REF | EP | |
| Designated contracting statesAK | AK | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0093551
- Publication, DOCDB
- 0093551
- Publication, EPODOC
- EP0093551
- Application
- 83302290
- Application, DOCDB
- 83302290
- Application, EPODOC
- EP19830302290
Titles3
- English
- Pharmaceutical composition
- French
- Composition pharmaceutique
- German
- Pharmazeutische Zusammensetzung
Classification
- CPC, 4
- A61K47/183
- A61K38/28
- A61K45/06
- C07K5/06078
- IPC, 4
- A61K38 28
- A61K45 06
- A61K47 18
- C07K5 065
Designated states3
- Contracting states, 3
- Germany
- France
- United Kingdom